Y-mAbs Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Y-mAbs Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2019 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 418 %, a 13.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 418 -65.9 -13.6% Sep 30, 2024
Q2 2024 448 -8.33 -1.83% Jun 30, 2024
Q1 2024 537 +68.9 +14.7% Mar 31, 2024
Q4 2023 506 +4.58 +0.91% Dec 31, 2023
Q3 2023 484 -79.7 -14.1% Sep 30, 2023
Q2 2023 456 -228 -33.4% Jun 30, 2023
Q1 2023 468 -365 -43.8% Mar 31, 2023
Q4 2022 501 -536 -51.7% Dec 31, 2022
Q3 2022 564 -482 -46.1% Sep 30, 2022
Q2 2022 684 -311 -31.2% Jun 30, 2022
Q1 2022 833 -115 -12.2% Mar 31, 2022
Q4 2021 1.04K +166 +19% Dec 31, 2021
Q3 2021 1.05K -47.3 -4.33% Sep 30, 2021
Q2 2021 995 -149 -13% Jun 30, 2021
Q1 2021 948 -166 -14.9% Mar 31, 2021
Q4 2020 871 -239 -21.5% Dec 31, 2020
Q3 2020 1.09K +5.66 +0.52% Sep 30, 2020
Q2 2020 1.14K -220 -16.2% Jun 30, 2020
Q1 2020 1.11K Mar 31, 2020
Q4 2019 1.11K Dec 31, 2019
Q3 2019 1.09K Sep 30, 2019
Q2 2019 1.36K Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.